Joe Walker
AeroLeads people directory · profile

Joe Walker Email & Phone Number

Location: Princeton, New Jersey, United States 8 work roles 3 schools
1 work email found @bms.com 1 phone found area 858 LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 86%

Contact Signals · 1 work email · 1 phone

Work email j****@bms.com
Direct phone (858) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Partner
Location
Princeton, New Jersey, United States

Who is Joe Walker? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Joe Walker is listed as Partner at Pacific Bridge NY, based in Princeton, New Jersey, United States. AeroLeads shows a work email signal at bms.com, phone signal with area code 858, and a matched LinkedIn profile for Joe Walker.

Joe Walker previously worked as Vice President & Sr Global Program Leader - Neuroscience at Bristol Myers Squibb and Executive Director & Senior Early Development Program Lead, Neuroscience at Bristol Myers Squibb. Joe Walker holds Post-Doctoral Fellowship from University Of Florida.

Company email context

Email format at Pacific Bridge NY

This section adds company-level context without repeating Joe Walker's masked contact details.

jwalker@bms.com
76% confidence

AeroLeads found 1 current-domain work email signal for Joe Walker. Compare company email patterns before reaching out.

Profile bio

About Joe Walker

Responsible/Accountable for all aspects of development of the assets in the BMS neuroscience portfolio. A Leader of Leaders.Leader of cross-functional matrixed development teams...including clinical, commercial, CMC, regulatory, clinical pharmacology, translational & biomarkers, clinical operations, toxicology, DM-PK, VAP/pricing, etc.Select Publications:Mega JL, Walker JR, Ruff CT, Vandell A, et al. “Genetics and the Clinical Response to Warfarin and Edoxaban” Lancet 2015; 385 (9984): 2280–2287.Mega J, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker J, Antman E, Macias W, Braunwald E, Sabatine M. “Cytochrome P450 Polymorphisms and the Pharmacologic and Clinical Response to Clopidogrel” New England Journal of Medicine 2009; 360(4):354-62.Walker JR, Brown K, Rohatagi S, Bathala MS, Xu C, Wickremasingha PK, Salazar DE, Mager DE. “Quantitative Structure-Property Relationships Modeling to Predict In Vitro and In Vivo Binding of Drugs to the Bile Sequestrant, Colesevelam (Welchol)” Journal of Clinical Pharmacology 2009; 49(10):1185-95.[Winner of 2010 McKeen Cattell Memorial Award for outstanding manuscript in the Journal of Clinical Pharmacology]Specific technical experience designing early clinical development strategies, companion diagnostic strategies, clinical pharmacology strategies, and personalization strategies; leading clinical pharmacology studies; and selection and validation of biomarkers within the diabetes, thrombosis, and oncology areas.Specialties: Global Program LeadershipEarly Drug DevelopmentNeuroscience, Neurology, NeurodegenerationAlzheimer's Disease, Multiple SclerosisMonoclonal antibodiesT Cell Engaging Bispecific antibodiesImmuno-oncologyCompanion Diagnostics (CDx) PharmacogenomicsClinical PharmacologyPersonalized MedicineProject Leadership

Current workplace

Joe Walker's current company

Company context helps verify the profile and gives searchers a useful next step.

Pacific Bridge NY
Pacific Bridge Ny
Partner
Princeton, NJ, US
AeroLeads page
8 roles

Joe Walker work experience

A career timeline built from the work history available for this profile.

Vice President & Sr Global Program Leader - Neuroscience

Lawrence Township, Nj, Us

Nov 2021 - Mar 2024

Executive Director & Senior Early Development Program Lead, Neuroscience

Lawrence Township, Nj, Us

Leader for Early Development of the neuroscience portfolio. (BMS acquired Celgene in 2019.)

Nov 2019 - Jan 2022

Executive Director, Global Project Leadership

Summit, New Jersey, Us

Led large global cross-functional drug development teams (which include clinical, nonclinical, CMC, regulatory, translational, commercial, project management, et al). Directly accountable to executive governance for overall vision, development strategy and execution from candidate nomination through IND / first-in-human to clinical proof of concept. Global Program Lead for CC-93269 (BCMA x CD3 bispecific antibody), CC-90002 (CD47 antibody), CC-94676 (Androgen Receptor Ligand-Directed Degrader), and CC-90003 (small molecule ERK inhibitor). Specific interest in model-based drug development and innovative drug development techniques.

Sep 2014 - Nov 2019

Senior Director, Companion Diagnostics & Pharmacogenomics

Basking Ridge, Nj, Us

Responsible for development, registration, and commercialization of companion diagnostics to accompany our therapeutic productsResponsible for strategic PGx activities across all therapeutic areas

Feb 2012 - Sep 2014

Director, Clinical Pharmacology, Oncology & Pharmacogenomics

Basking Ridge, Nj, Us

Responsible for creation and execution of innovative early clinical development strategies (FIH --> PoC). The goal is to efficiently clarify the major in vivo properties of a drug candidate in order to support early Go/No-Go decisions. Developed and executed the clinical pharmacology components of a clinical development plan at all stages of development in order to support dose selection, formulation selection, appropriate use of the drug, labeling, and registration. Developed and executed clinical pharmacogenomic and biomarker research plans that support drug differentiation and personalization strategies.

Apr 2006 - Feb 2012

Manager, Clinical Pharmacology & Pharmacokinetics

Basking Ridge, Nj, Us

Aug 2003 - Apr 2006

Associate Director, Pharmacogenomics

Orchid GeneShield - an innovative personalized medicine company.Lead efforts to create an ADR (adverse drug reaction) risk assessment tool using PGx and EMR (electronic medical records) data. This was an early forerunner of the current 'consumer genetics' products such as '23 and me', Navigenics, deCodeMe, etc.Conducted Clinical Pharmacology studies to evaluate PGx effects on drug response (safety, efficacy, PK/PD)

Jul 2000 - Aug 2003
3 education records

Joe Walker education

Post-Doctoral Fellowship

University Of Florida

Residency

Emory University

Pharmd

University Of Tennessee
FAQ

Frequently asked questions about Joe Walker

Quick answers generated from the profile data available on this page.

What company does Joe Walker work for?

Joe Walker works for Pacific Bridge NY.

What is Joe Walker's role at Pacific Bridge NY?

Joe Walker is listed as Partner at Pacific Bridge NY.

What is Joe Walker's email address?

AeroLeads has found 1 work email signal at @bms.com for Joe Walker at Pacific Bridge NY.

What is Joe Walker's phone number?

AeroLeads has found 1 phone signal(s) with area code 858 for Joe Walker at Pacific Bridge NY.

Where is Joe Walker based?

Joe Walker is based in Princeton, New Jersey, United States while working with Pacific Bridge NY.

What companies has Joe Walker worked for?

Joe Walker has worked for Pacific Bridge Ny, Bristol Myers Squibb, Celgene, Daiichi Sankyo, and Orchid Cellmark.

How can I contact Joe Walker?

You can use AeroLeads to view verified contact signals for Joe Walker at Pacific Bridge NY, including work email, phone, and LinkedIn data when available.

What schools did Joe Walker attend?

Joe Walker holds Post-Doctoral Fellowship from University Of Florida.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.